Management of Symptomatic Hypotension in Patients with Low Blood Pressure

Immediate Assessment and Medication Adjustment

The European Society of Cardiology recommends reviewing all medications that can lower blood pressure, including beta-blockers, calcium channel blockers, diuretics, and central-acting agents, to identify the cause of hypotension 1
Assessing for orthostatic symptoms (dizziness, lightheadedness, weakness, syncope) and measuring blood pressure in both supine and standing positions is crucial in patients with symptomatic hypotension 2
Reducing diuretic doses first if volume depletion is suspected, and considering halving doses of other antihypertensives rather than stopping completely, can help manage symptomatic hypotension 3

Diuretics can often be reduced or temporarily held without rebound, according to the European Heart Journal 3
ACE inhibitors and ARBs are generally safer to adjust, as stated in the European Heart Journal 3

The European Society of Cardiology recommends maintaining BP-lowering treatment lifelong if well tolerated, but with appropriate dosing, as outlined in the 2024 ESC Guidelines 4
Target systolic BP should be 120-129 mmHg in most adults, not below this range, as recommended by the European Society of Cardiology 4
Applying the "as low as reasonably achievable" (ALARA) principle rather than fixed targets is recommended if treatment is poorly tolerated, according to the European Heart Journal 4
Reassessing cardiovascular risk and considering slower up-titration or lower dosing is more appropriate, particularly in elderly patients or those with frailty, as stated in the European Heart Journal 5

Contacting a physician immediately and temporarily reducing or holding diuretics if volume depleted (under medical guidance) is recommended, as advised by the European Heart Journal 3
The American Heart Association is not mentioned in this article, however the European Heart Journal recommends monitoring BP daily during medication adjustments and watching for rebound hypertension in the weeks following any medication changes is not cited, but monitoring and adjusting is generally a good practice 3